Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.47 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.36 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6522112 | 0.92 | CPB2 (0.51) | CPB2CYP4F2CYP4A11CA1CA2 | |
| SCHEMBL17523695 | 0.89 | HDAC1 (0.44) | CPB2CYP4F2CYP4A11CA1CA2 | |
| SCHEMBL28078262 | 0.89 | HDAC1 (0.44) | CPB2CYP4F2CYP4A11CA1CA2 | |
| SCHEMBL5000143 | 0.88 | CPB2 (0.47) | CPB2CYP4F2CYP4A11CA1CA2 | |
| SCHEMBL1101304 | 0.86 | CPB2 (0.51) | CPB2CA1CA2LMNA | |
| SCHEMBL15903982 | 0.86 | CPB2 (0.51) | CPB2CA1CA2LMNA | |
| SCHEMBL28448275 | 0.86 | CPB2 (0.51) | CPB2CA1CA2LMNA | |
| SCHEMBL15903942 | 0.86 | CPB2 (0.51) | CPB2CA1CA2LMNA | |
| SCHEMBL11128494 | 0.86 | CPB2 (0.51) | CPB2CA1CA2LMNA | |
| SCHEMBL9256335 | 0.86 | CPB2 (0.60) | CPB2CYP4F2CYP4A11CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117561268-A | Targeting ligands and uses thereof | 上海金中锘美生物医药科技有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-116801886-A | LPA inhibitors and uses thereof | 上海金中锘美生物医药科技有限公司 | 2023-09-22 | — | — | CN | disclosed |
| WO-2023138664-A1 | TARGETING LIGAND AND USE THEREOF | 上海金中锘美生物医药科技有限公司 | 2023-07-27 | — | — | WO | disclosed |
| EP-1510356-B1 | Imageable elements containing cyanoacrylate polymer particles | EASTMAN KODAK CO (US) | 2007-04-25 | — | — | EP | disclosed |
| US-7070902-B2 | Imageable elements containing cyanoacrylate polymer particles | EASTMAN KODAK COMPANY (US) | 2006-07-04 | — | — | US | disclosed |
| US-20060093554-A1 | Galenical formulations | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2006-05-04 | — | — | US | disclosed |
| US-20050074409-A1 | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2005-04-07 | — | — | US | disclosed |
| US-20050048396-A1 | Imageable elements containing cyanoacrylate polymer particles | KODAK (NEAR EAST) INC. | 2005-03-03 | — | — | US | disclosed |
| EP-1510356-A1 | Imageable elements containing cyanoacrylate polymer particles | Kodak Polychrome Graphics, LLC (US) | 2005-03-02 | — | — | EP | disclosed |
| US-6818203-B2 | COMPLEXES HAVE CRITICAL MICELLE FORMATION CONCENTRATION, HYDRODYNAMIC MICELLE DIAMETER, AND PROTON RELAXIVITY IN PLASMA CONTRAST MEDIA IN MR IMAGING | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-11-16 | — | — | US | disclosed |
| CN-1469757-A | Use of metal complexes containing perfluoroalkyl as contrast agents in MR-imaging for the representation of plaques, tumours and necroses | ���ֹɷݹ�˾ | 2004-01-21 | — | — | CN | disclosed |
| US-20030072713-A1 | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2003-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030072713-A1 | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses | FABP3, PRF1, PTDSS1 | CPB2 1933/4885CYP4F2 2853/4885CYP4A11 3548/4885 |
| US-20050074409-A1 | Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses | FABP3, PRF1, MALT1 | CPB2 2498/4885CYP4F2 3095/4885CYP4A11 3069/4885 |
| US-20060093554-A1 | Galenical formulations | GALC, GALR2, GALR1 | CPB2 3330/4885CYP4F2 1851/4885CYP4A11 3391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.